Prestige News

Total 66
Number Thumbnail Title Author Date Votes Views
16 Prestige Biopharma's Busan Innovative Drug Discovery Center (IDC) Designated as Advanced Investment Zone
김** | 2023.09.11 | Votes 0 | Views 346
김** 2023.09.11 0 346
15 Prestige Biopharma and Imagion Biosystems Sign an MOU, Developing Early Pancreatic Cancer Diagnosis Platform
김** | 2023.08.11 | Votes 0 | Views 368
김** 2023.08.11 0 368
14 Prestige Biopharma Submits EMA Marketing Authorization Application for Herceptin Biosimilar HD201
김** | 2023.07.31 | Votes 0 | Views 363
김** 2023.07.31 0 363
13 Prestige Biopharma Receives FDA Fast Track Designation for PBP1510 in the Treatment of Pancreatic Cancer
김** | 2023.03.16 | Votes 0 | Views 331
김** 2023.03.16 0 331
12 Prestige Biopharma Initiates Development of PAUF-Based Diagnostic Kit for Pancreatic Cancer
김** | 2023.03.09 | Votes 0 | Views 329
김** 2023.03.09 0 329
11 Prestige Biopharma Receives Approval for Phase 1 Trial of Humira Biosimilar in Hungary
김** | 2023.02.15 | Votes 0 | Views 315
김** 2023.02.15 0 315
10 Prestige Biopharma Secures Korean Patent for PBP1710, an Antibody Therapeutic for Solid Tumors
김** | 2023.01.10 | Votes 0 | Views 258
김** 2023.01.10 0 258
9 Prestige Biopharma Attracts Over 300 Companies to Its Booth at CPHI
we******** | 2022.11.07 | Votes 0 | Views 391
we******** 2022.11.07 0 391
8 Prestige Biopharma Identifies New Biomarker for Pancreatic Cancer Treatment
we******** | 2022.10.05 | Votes 0 | Views 349
we******** 2022.10.05 0 349
7 Prestige Biopharma Receives FDA Approval for Phase 1/2a Trial of Pancreatic Cancer Drug PBP1510
김** | 2022.06.27 | Votes 0 | Views 536
김** 2022.06.27 0 536